In our subjective every-day experience, it is apparent that odor memories are fundamentally different from other memories; however, the phenomenon has proved to be notoriously difficult to study under controlled laboratory conditions. Yeshurun et al. 's [3] approach of combining associative memory tests with functional magnetic resonance imaging allowed them to study how odor memories are different at the neuronal level. The identification of brain regions implicated in the formation of first-learned associations between odors and objects opens the door for research that will explicate the role of olfactory processing, emotion, and long-term memory in this intriguing phenomenon. Phagocytosis: Invitation to a Feast How does a macrophage find an apoptotic cell for ingestion? A recent study shows that ATP and UTP released from the dying cell serve as important chemoattractants for macrophages and are key contributors to the efficient clearance of apoptotic cells in vivo.
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The deletion of excess, previously used, unwanted or damaged cells is essential in metazoa for development, metamorphoses, tissue homeostasis, responses to injury and for the development and regulation of innate and adaptive immunity. It is achieved by the induction of various forms of programmed cell death (PCD), of which apoptosis is the best known. Critical to the overall process, however, is the subsequent recognition and removal of the dying cell in a manner that can distinguish between PCD and cell death induced by external agents, toxins, physical damage or, particularly, infectious agents. For the former, a quiet efficient removal is the norm whereas, for the latter, the animal needs to (and does) mount a protective response that can encompass engagement of the various innate and adaptive immune processes with which it is endowed. In mammals, this is represented by the commonly noted but also overly simplified distinction between the non-inflammatory and non-immunogenic response to apoptotic cells versus the proinflammatory and pro-immunogenic effects of cells dying by non-PCD (often loosely described as necrotic) pathways.
Dying cells are removed by uptake into phagocytic cells. In simpler invertebrates, such as nematodes, this is largely achieved by recognition by, and uptake into, neighboring tissue cells, and in fact this near-neighbor removal can also occur in mammals, as exemplified by post-lactation remodeling of the mammary gland or, for that matter, the constant daily removal of retinal outer rod segments, each achieved by epithelial cells. But in animals with more professional and mobile phagocytes, these have taken on the major role in recognition, phagocytosis and digestion of the cells undergoing PCD. Many studies have addressed these processes and shown them to involve unique mechanisms of uptake (often involving ingestion of intact cells that can be as large as 20mm in diameter), unique sets of receptors and bridge molecules (opsonins), and unique intracellular signaling pathways, with remarkable evolutionary conservation of the entire process [1] [2] [3] . However, the important question of how the mobile phagocyte finds (is attracted to) the cells undergoing PCD has received much less attention. This is the subject addressed in the recent paper by Elliot et al. [4] which reports identification of the nucleotides ATP and UTP as prime candidates for what have been colloquially called 'find me' signals, following the various use of 'eat me' and 'don't eat me' for apoptotic cell uptake or inhibitory signals, respectively.
The approach taken by Elliot et al. [4] was to show release of chemotactic factors for macrophages from apoptotic cells in vitro, confirm with macrophage attraction into skin pouches in mice, identify candidate molecules released from the apoptotic cells and finger the likely receptors on macrophages that were responsible. To complete the story, they showed that removal of the factors or blockade of the candidate receptors reduced clearance of apoptotic cells in an in vivo model cell removal system following massive lymphocyte apoptosis in the thymus, which was first described by Scott et al. [5] . Their extensive series of experiments led to the identification of ATP and UTP as responsible molecules for apoptotic cell attraction of macrophages. These nucleotides are released from a variety of cells undergoing apoptosis in a caspase-dependent fashion, apparently before the cells undergo loss of plasma membrane permeability. They induce macrophage chemotaxis in vitro and in vivo, and apoptotic cell supernate induction of the macrophage attraction was shown to be abrogated by introduction of apyrase to hydrolyze the nucleotides. Overexpression of CD39 -a mammalian ecto-enzyme involved in natural nucleotide inactivation -was shown to have a similar blocking effect.
Important studies by Inoue and colleagues [6, 7] had previously implicated nucleotides in the regulation of dead cell clearance by the microglial cells of the brain. These, like peripheral macrophages, are members of the mononuclear phagocyte system, arise from the same myeloid precursors and serve as the endogenous macrophages of the central nervous system. But these investigators suggested a possible distinction between ATP (and ADP) as microglial attractants and UDP as an enhancer of the subsequent phagocytic step. By contrast, Elliot et al. [4] showed equal effects of both ATP and UTP in their attraction studies in vitro and in the periphery (skin), and a markedly weaker effect of ADP. Differences in purinergic receptor usage between the two sets of studies were also noted and may suggest differences in receptor expression between peripheral macrophages and microglia or merely technical differences between the different systems -certainly a candidate for future investigation.
Elliot et al. [4] showed that ATP and UTP are both involved in the macrophage migratory response to apoptotic cells, and both appear to act through the P2Y 2 receptor, as shown by the effect of blocking or knocking down this receptor, and the ineffectiveness of apoptotic cell supernates to induce macrophage attraction in P2Y 2 knockout mice. An important validating result was the demonstration that apyrase administration or the use of the P2Y 2 2/2 mice resulted in blockade of the normally rapid clearance of thymocytes following their glucocorticoid-induced apoptosis. These experiments were used by the authors to suggest that the nucleotide attractants they describe are essential for macrophage attraction (Figure 1) .
While this might be the case in this particular system, it must be noted that other 'find me' signals have been suggested. In normal resolution of the corpus luteum, macrophages accumulate and are responsible for clearance of the dying luteal cells. Here, induction of the monocyte/ macrophage chemoattractant chemokine (CCL12, MCP-1) from remaining viable cells apparently responding to the neighboring apoptotic cells seemed to mediate the attraction [8, 9] . This may be a mechanism that applies in other situations in vivo. Another chemokine candidate that has been invoked is CX3CL1 (fractalkine): a deficiency of its receptor (CX3CR1) was shown to diminish accumulation of macrophages to lymphoid follicle germinal centers, presumably to the apoptotic cells at that site [10] . Interest here may extend to the important role played by this molecule in selective accumulation of monocyte subsets from the blood (for example, [11, 12] ). At issue may be which cell types can release this chemokine as they undergo apoptosis.
Lauber et al. [13] identified lysophosphatidylcholine as a completely different macrophage attractant that was released from apoptotic cells in vitro. Elliot et al. [4] went to some lengths to address this interesting candidate and could find no evidence for its involvement, either in vitro or in vivo. A potential explanation for this difference may be the status of the apoptosing cell, as the Lauber studies required prolonged incubation after initiating the apoptosis and their results may be more indicative of the post-apoptotic (secondary) necrosis stage of cell death that results in vivo if the dying cells are not removed. Apoptotic cells have, however, been shown to expose lysophosphatidylcholine on their surface, which, in some circumstances, may participate in autoimmunity [14] . Again, the timepoint at which this exposure/expression occurs may be a key issue. A general point in considering the various processes involved in apoptotic (PCD) cell removal is the considerable redundancy that appears to be involved in, for example, receptor usage for their recognition, signal pathways for uptake, and perhaps now, attractant molecules to get the macrophages to the site of cell death. It is attractive to attribute such redundancy to the 'importance' of the processes, as well as to their likely selective control in different sites and situations.
This raises the question of which cell is in fact attracted to sites at which cells are undergoing PCD? For the most part, mononuclear phagocytes arise from precursors in the bone marrow, enter the circulation as monocytes which then penetrate the tissues, and mature into tissue macrophages and myeloid dendritic cells (as well as the more tissue-specific variants, such as Kupfer cells, osteoclasts, microglia, and so on). Cells undergoing apoptosis might, therefore, either attract resident tissue macrophages or dendritic cells from within the tissue, and/or new As cells become apoptotic (here represented by neutrophils), they release ATP and UTP which attract macrophages within the tissues, and/or monocytes migrating from the blood, to ingest and remove the dying cells. Nucleotidases on nearby cells, or even on the apoptotic cells or macrophages themselves, would be expected to regulate this effect by destroying the chemoattractants.
monocytes from the blood. The latter would then be expected to mature within the tissue to gain the phagocytic potential to ingest the apoptotic cells. (Blood monocytes appear to be inefficient in this regard, in part, perhaps, because they need to develop an appropriate size and membrane pool, not to mention the appropriate receptors and signaling capability, to ingest whole apoptotic cells or apoptotic bodies.) The in vivo studies by Elliot et al. [4] (or the other studies indentified above) do not distinguish between these possibilities, although the microglial systems are less likely to involve emigration from the blood since this would require breach of the blood-brain barrier. Accordingly, they might represent a system for focusing on the attraction of resident 'macrophages' to local sites of cell death.
There is substantial current interest in roles played in tissues by emigration of monocyte subsets, especially those exhibiting differential expression of CX3CR. Following the demonstration by Elliot et al. [4] of a role for P2Y 2 , one might reasonably question the extent of its expression on monocytes and monocyte subsets as well as on the very widely variable subsets of macrophages seen in vivo. We know already that different macrophage populations show wide variability in the apoptotic cell recognition receptors that they express, so a comparable complexity may apply to possible different attractant receptors, with the presumption that this contributes greater degrees of control over the processes at different sites and in different circumstances. One must also raise the question of attraction of dendritic cells to sites of cell death; the cells migrating into the skin pouches shown by Elliot et al. [4] might have included dendritic cells, with relevant implications for their complex roles in immunologic regulation.
Thus, many fascinating questions remain. For example, how are the nucleotides, generally thought to be membrane impermeable, released from the apoptosing cells? Why are they not rapidly destroyed by ecto-nucleotidases as was shown in the overexpression of CD39. If such enzymes are lost on the actual dying cell, they would still be expected to be present on nearby viable cells. Some cells, such as platelets, release ATP when activated and a series of fascinating studies has shown that neutrophils emigrating through epithelia can themselves, or perhaps with attached platelets, also release ATP [15, 16] . Might such emigration, especially if it applied to emigration through endothelia as well, also contribute to the monocyte/ macrophage accumulation that occurs in neutrophilic inflammation (although many other monocyte chemoattractants have already been implicated in this).
In this regard, a remaining concern with the work of Elliot et al. [4] using the air-pouch model is whether an earlier accumulation of neutrophils, which themselves can generate a number of monocyte chemoattractants, contributed to the attraction of monocytes/macrophages that was assessed at 24 hours. What in fact is the effect of the nucleotides on other inflammatory cells such as neutrophils? They too express P2Y receptors (as noted in the commentary by Gregory [17] ). Then one could consider the potential effects of the nucleotide release from necrotic cells? Again this could have just as valid implications for attraction of macrophages to mediate the clearance of cell debris, though in this case the consequence would presumably be pro-inflammatory rather than the silent, inflammosuppressive and immunosuppressive outcome seen with cells undergoing programmed cell death. What are the other consequences for the monocytes or macrophages of ATP/UTP stimulation through P2Y 2 or other purinergic receptors. A possible enhancement of the subsequent cell uptake has already been noted above and Elliot et al. [4] themselves raised the question of a contribution to the inflammosuppression. If it is primarily the monocyte that is attracted, might there be a role for the local nucleotides in their maturation, and if so, to result in what specific macrophage phenotypic properties?
